(MENAFN- Market Press Release) July 18, 2025 7:15 am - Industry revenue for Iv Securement Device is estimated to rise to $4.0 billion by 2035 from $1.4 billion of 2024. The revenue growth of market ...
3M PICC / CVC Securement Device + Tegaderm CHG Chlorhexidine Gluconate IV Securement Dressing (3M). 3M’s PICC / CVC Securement Device secures an IV without sutures using silicone adhesives. The ...
BETHLEHEM, Pa., Sept. 27, 2022 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, announced today it has acquired the innovative Clik-FIX catheter ...
The global IV therapy and vein access devices market is projected to reach an impressive USD 28.7 billion by 2024, with a forecasted growth rate of 5.1% CAGR, bringing the market value to an estimated ...
WILLIAMSTON, Mich.--(BUSINESS WIRE)--As demand for SorbaView SHIELD ® Securement System increases, with more than 9.7 million sold in the past 12 months in hospitals and healthcare facilities across ...
The global IV therapy and vein access devices market is on a trajectory of significant growth, projected to expand from USD 28.7 billion in 2024 to an estimated USD 47.3 billion by 2034. With a ...
SecurePort IV (Adhezion Biomedical) is a cyanoacrylate tissue adhesive intended for use in people having a percutaneous catheter inserted. Percutaneous catheters are associated with complications such ...
Vascular Pathways Inc., a privately held medical device manufacturer with a breakthrough product for peripheral intravenous access, today announced that the company has elected Eugene (“Gene”) T.
Hospitalised paediatric patients are not 'little adults' and require specialised care and treatment. At the 3M's IV Leadership Summit: Excellence in Vascular Access in four major South African cities, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback